Allen, P. B., & LaCasce, A. S. (2019). Evidence-Based Minireview: What is the optimal timing of anti–PD-1 antibodies in relapsed classical Hodgkin lymphoma? Hematology Am Soc Hematol Educ Program.
Chicago Stili AlıntıAllen, Pamela Blair, ve Ann S. LaCasce. "Evidence-Based Minireview: What Is the Optimal Timing of Anti–PD-1 Antibodies in Relapsed Classical Hodgkin Lymphoma?" Hematology Am Soc Hematol Educ Program 2019.
MLA AlıntıAllen, Pamela Blair, ve Ann S. LaCasce. "Evidence-Based Minireview: What Is the Optimal Timing of Anti–PD-1 Antibodies in Relapsed Classical Hodgkin Lymphoma?" Hematology Am Soc Hematol Educ Program 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..